Aurobindo Pharma approves ₹800 cr shares buyback

The Board of Aurobindo Pharma has on Monday approved a proposal to buyback upto 54.23 lakh fully paid-up equity shares of the company, each having a face value of ₹1 representing upto 0.93 per cent of the total number of equity shares in the paid-up equity share capital.

The buyback will be at a price of ₹1,475 per equity share payable in cash for an aggregate amount up to ₹800 crore.

The buyback size does not include transaction costs such as brokerage costs, fees, turnover charges, and applicable taxes.

The buyback is proposed to be made from all of the equity shareholders/beneficial owners of the Hyderabad-based company, including the promoters and members of the promoter group, the BSE was informed on Monday.

Published on April 6, 2026